Bank Of America Corp Aptinyx Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.69 $12 - $71	-104 Reduced 11.5%	800 $0
Q4 2022 Feb 10, 2023	SELL	$0.23 - $0.34 $33 - $49	-146 Reduced 13.9%	904 $0
Q3 2022 Nov 14, 2022	BUY	$0.35 - $0.72 $367 - $756	1,050 New	1,050 $0
Q1 2022 May 16, 2022	BUY	$2.27 - $3.62 $10,843 - $17,292	4,777 Added 174.73%	7,511 $17,000
Q4 2021 Feb 08, 2022	SELL	$2.11 - $3.0 $11,334 - $16,116	-5,372 Reduced 66.27%	2,734 $8,000
Q3 2021 Nov 15, 2021	SELL	$2.21 - $2.89 $61,577 - $80,524	-27,863 Reduced 77.46%	8,106 $19,000
Q2 2021 Sep 13, 2021	BUY	$2.39 - $3.5 $85,965 - $125,891	35,969 New	35,969 $102,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.